Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION safely and effectively. See full prescribing information for CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE TOPICAL SUSPENSION. CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE, for topical suspension Initial U.S. Approval: 2006
Medication labelWhy this: Advisory · dailymed-prescription
Calcipotriene and Betamethasone Dipropionate Topical Suspension is indicated for the topical treatment of plaque psoriasis of the scalp in patients 12 years and older and plaque psoriasis of the scalp and body in patients 18 years and older. Additional pediatric use information is approved for LEO Pharma A/S's Taclonex ®(calcipotriene and betamethasone dipropionate) Topical Suspension. However, due to LEO Pharma A/S's marketing exclusivity rights, this drug product is not labeled with that information.
- generic_name
- calcipotriene and betamethasone dipropionate
- product_names
- Calcipotriene and Betamethasone Dipropionate
- ndc
- 51672-1402, 51672-1402-4, 51672-1402-8
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en